Omnicell

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Omnicell and other ETFs, options, and stocks.

About OMCL

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation. 

CEO
Randall A. Lipps
CEORandall A. Lipps
Employees
3,670
Employees3,670
Headquarters
Fort Worth, Texas
HeadquartersFort Worth, Texas
Founded
1992
Founded1992
Employees
3,670
Employees3,670

OMCL Key Statistics

Market cap
1.94B
Market cap1.94B
Price-Earnings ratio
102.86
Price-Earnings ratio102.86
Dividend yield
Dividend yield
Average volume
677.92K
Average volume677.92K
High today
$43.97
High today$43.97
Low today
$42.60
Low today$42.60
Open price
$43.93
Open price$43.93
Volume
551.09K
Volume551.09K
52 Week high
$47.69
52 Week high$47.69
52 Week low
$22.66
52 Week low$22.66

Stock Snapshot

With a market cap of 1.94B, Omnicell(OMCL) trades at $43.27. The stock has a price-to-earnings ratio of 102.86.

On 2025-12-16, Omnicell(OMCL) stock moved within a range of $42.60 to $43.97. With shares now at $43.27, the stock is trading +1.6% above its intraday low and -1.6% below the session's peak.

Trading volume for Omnicell(OMCL) stock has reached 551.09K, versus its average volume of 677.92K.

Over the past 52 weeks, Omnicell(OMCL) stock has traded between a high of $47.69 and a low of $22.66.

Over the past 52 weeks, Omnicell(OMCL) stock has traded between a high of $47.69 and a low of $22.66.

OMCL News

Simply Wall St 6d
Is Omnicell’s Titan XT Launch a Turning Point in Its SaaS Automation Strategy?

Omnicell recently launched Omnicell Titan XT in the United States, an enterprise-grade automated dispensing system powered by its cloud-based, HITRUST-certified...

Is Omnicell’s Titan XT Launch a Turning Point in Its SaaS Automation Strategy?
TipRanks 7d
Omnicell price target raised to $46 from $36 at BofA

BofA analyst Allen Lutz raised the firm’s price target on Omnicell (OMCL) to $46 from $36 and keeps a Neutral rating on the shares after the company announced y...

Analyst ratings

63%

of 8 ratings
Buy
62.5%
Hold
37.5%
Sell
0%

People also own

Based on the portfolios of people who own OMCL. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.